The following is a summary of "Insights from the European Nontuberculous mycobacterial Pulmonary Disease Patient Disease ...
Early diagnosis and treatment of active Tuberculosis is utmost priority, but identifying the latent TB, especially among the ...
I suffered extensive fatigue that I had attributed to a COVID-19 infection. Then a lung culture found something called ...
The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...
An outbreak of tuberculosis, or TB – a lung disease that is often accompanied by a hacking cough – began in January 2024 in ...
The Bronchiectasis and NTM Association has accepted 27 Care Center and six Clinical Associate Center sites in 23 states and the District of Columbia into the new Bronchiectasis and NTM Care Center ...
suggesting that the scores measured from either PRO may be fit-for-purpose in evaluating response to treatment in patients with treatment-refractory NTM lung disease. The Company reported Phase 2 ...
The FDA has made it clear that the primary bar for NTM drug approval is patient-reported improvement in NTM symptoms. Our recent statistical analysis plan submission provides the opportunity to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback